Jiangsu Hengrui Medicine Co., Ltd.
600276
Ранг среди акций
#548
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
Цена акции
$6.89
Рыночная капитализация
$43.94B
Изменение (1 день)
-2.91%
Изменение (1 год)
-24.78%
Страна
CN
Торговля Jiangsu Hengrui Medicine Co., Ltd. (600276)
Категория
Healthcare
История цены акций Jiangsu Hengrui Medicine Co., Ltd. (600276)
Наивысшая цена закрытия: $6.77 2026-10-01
Наименьшая цена закрытия: $0.04 2005-07-01
Наименьшая цена закрытия: $0.04 2005-07-01
История цены акций Jiangsu Hengrui Medicine Co., Ltd. с 2005 по 2026
Годовая динамика цены акций
| Год | Результативность |
|---|---|
| 2026 (TTM) | -9.37% |
| 2025 | 33.70% |
| 2024 | 2.96% |
| 2023 | 15.17% |
| 2022 | -30.24% |
| 2021 | -37.82% |
| 2020 | 50.21% |
| 2019 | 73.88% |
| 2018 | 25.89% |
| 2017 | 85.51% |
| 2016 | 3.95% |
| 2015 | 100.95% |
| 2014 | 12.39% |
| 2013 | 42.52% |
| 2012 | 4.92% |
| 2011 | -16.03% |
| 2010 | 40.18% |
| 2009 | 61.62% |
| 2008 | -8.70% |
| 2007 | 153.91% |
| 2006 | 239.46% |
| 2005 | 0.00% |
Цена акций похожих компаний или конкурентов
| Компания | Цена акций | Изменение 1г% | Страна |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
